This essential work, edited by two researchers at London 's famous Queen Mary 's medical school targets one of the most important areas in medical development today. These days, antibody therapeutics are the treatment of choice for several autoimmune and oncological conditions. They are, indeed, becoming the molecules of choice for further combination therapies and cell engineering. In this timely work, a slew of expert in the field of drug development summarize all the current developments and clinical successes.
Or split into 4x interest-free payments of 25% on orders over R50
Learn more
This essential work, edited by two researchers at London 's famous Queen Mary 's medical school targets one of the most important areas in medical development today. These days, antibody therapeutics are the treatment of choice for several autoimmune and oncological conditions. They are, indeed, becoming the molecules of choice for further combination therapies and cell engineering. In this timely work, a slew of expert in the field of drug development summarize all the current developments and clinical successes.
Imprint | Springer-Verlag |
Country of origin | Germany |
Series | Handbook of Experimental Pharmacology, 181 |
Release date | November 2007 |
Availability | Expected to ship within 9 - 15 working days |
First published | 2008 |
Editors | Yuti Chernajovsky, Ahuva Nissim |
Dimensions | 235 x 155 x 24mm (L x W x T) |
Format | Hardcover |
Pages | 380 |
Edition | 2008 ed. |
ISBN-13 | 978-3-540-73258-7 |
Barcode | 9783540732587 |
Categories | |
LSN | 3-540-73258-6 |